The departing chairman of the Swiss drug maker says the company will have more flexibility to pursue acquisitions in the coming year as it pays down debt.
from WSJ.com: US Business http://ift.tt/1eYPop6
via IFTTT
from WSJ.com: US Business http://ift.tt/1eYPop6
via IFTTT
No comments:
Post a Comment